Sidney H Kennedy, M.D. - Publications

Affiliations: 
University of Toronto, Toronto, ON, Canada 

225 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Suh JS, Fiori LM, Ali M, Harkness KL, Ramonas M, Minuzzi L, Hassel S, Strother SC, Zamyadi M, Arnott SR, Farzan F, Foster JA, Lam RW, MacQueen GM, Milev R, ... ... Kennedy SH, et al. Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report. Psychoneuroendocrinology. 132: 105348. PMID 34229186 DOI: 10.1016/j.psyneuen.2021.105348  0.44
2021 Nunez JJ, Nguyen TT, Zhou Y, Cao B, Ng RT, Chen J, Frey BN, Milev R, Müller DJ, Rotzinger S, Soares CN, Uher R, Kennedy SH, Lam RW. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1. Plos One. 16: e0253023. PMID 34181661 DOI: 10.1371/journal.pone.0253023  0.32
2021 Allen TA, Harkness KL, Lam RW, Milev R, Frey BN, Mueller DJ, Uher R, Kennedy SH, Quilty LC. Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report. Personality and Mental Health. PMID 34008342 DOI: 10.1002/pmh.1514  0.32
2021 Shakeel MK, Hassel S, Davis AD, Metzak PD, MacQueen GM, Arnott SR, Bray S, Frey BN, Goldstein BI, Hall GB, Harris J, Lam RW, MacIntosh BJ, Milev R, Mueller DJ, ... ... Kennedy SH, et al. White matter microstructure in youth at risk for serious mental illness: A comparative analysis. Psychiatry Research. Neuroimaging. 312: 111289. PMID 33910139 DOI: 10.1016/j.pscychresns.2021.111289  0.44
2021 Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, McInerney S, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. Cns Drugs. 35: 439-450. PMID 33860922 DOI: 10.1007/s40263-021-00803-2  0.32
2021 Theyers AE, Zamyadi M, O'Reilly M, Bartha R, Symons S, MacQueen GM, Hassel S, Lerch JP, Anagnostou E, Lam RW, Frey BN, Milev R, Müller DJ, Kennedy SH, Scott CJM, et al. Multisite Comparison of MRI Defacing Software Across Multiple Cohorts. Frontiers in Psychiatry. 12: 617997. PMID 33716819 DOI: 10.3389/fpsyt.2021.617997  0.44
2021 Chakrabarty T, McInerney SJ, Torres IJ, Frey BN, Milev RV, Müller DJ, Rotzinger S, Kennedy SH, Lam RW. Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Cns Drugs. PMID 33683582 DOI: 10.1007/s40263-021-00793-1  0.32
2021 Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry. PMID 33652477 DOI: 10.1055/a-1385-0263  0.32
2021 Marshe VS, Maciukiewicz M, Hauschild AC, Islam F, Qin L, Tiwari AK, Sibille E, Blumberger DM, Karp JF, Flint AJ, Turecki G, Lam RW, Milev RV, Frey BN, Rotzinger S, ... ... Kennedy SH, et al. Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational Psychiatry. 11: 127. PMID 33589590 DOI: 10.1038/s41398-021-01248-3  0.32
2021 Farris MS, Braun A, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Addington J. Longitudinal Trends in Medication Treatment for Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720988450. PMID 33464130 DOI: 10.1177/0706743720988450  0.48
2020 Vaccarino AL, Kalali AH, Blier P, Gilbert Evans S, Engelhardt N, Foster JA, Frey BN, Greist JH, Kobak KA, Lam RW, MacQueen G, Milev R, Müller DJ, Parikh SV, Placenza FM, ... ... Kennedy SH, et al. THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial. Innovations in Clinical Neuroscience. 17: 30-40. PMID 33520402  0.48
2020 McInerney SJ, Chakrabarty T, Maciukiewicz M, Frey BN, MacQueen GM, Milev RV, Ravindran AV, Rotzinger S, Kennedy SH, Lam RW. Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720974823. PMID 33353384 DOI: 10.1177/0706743720974823  0.44
2020 Ge R, Hassel S, Arnott SR, Davis AD, Harris JK, Zamyadi M, Milev R, Frey BN, Strother SC, Müller DJ, Rotzinger S, MacQueen GM, Kennedy SH, Lam RW, Vila-Rodriguez F. Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110194. PMID 33296696 DOI: 10.1016/j.pnpbp.2020.110194  0.44
2020 Metzak PD, Addington J, Hassel S, Goldstein BI, MacIntosh BJ, Lebel C, Wang JL, Kennedy SH, MacQueen GM, Bray S. Functional imaging in youth at risk for transdiagnostic serious mental illness: Initial results from the PROCAN study. Early Intervention in Psychiatry. PMID 33295151 DOI: 10.1111/eip.13078  0.44
2020 Swainson J, McGirr A, Blier P, Brietzke E, Richard-Devantoy S, Ravindran N, Blier J, Beaulieu S, Frey BN, Kennedy SH, McIntyre RS, Milev RV, Parikh SV, Schaffer A, Taylor VH, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720970860. PMID 33174760 DOI: 10.1177/0706743720970860  0.32
2020 Addington J, Liu L, Farris MS, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, MacQueen G. Clinical staging for youth at-risk for serious mental illness: A longitudinal perspective. Early Intervention in Psychiatry. PMID 33037783 DOI: 10.1111/eip.13062  0.48
2020 Nogovitsyn N, Addington J, Souza R, Placsko TJ, Stowkowy J, Wang J, Goldstein BI, Bray S, Lebel C, Taylor VH, Kennedy SH, MacQueen G. Childhood trauma and amygdala nuclei volumes in youth at risk for mental illness. Psychological Medicine. 1-8. PMID 32940197 DOI: 10.1017/S0033291720003177  0.48
2020 Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G, Parikh SV, Milev R, MacQueen G, Lam RW, Kennedy SH, et al. Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 81. PMID 32558407 DOI: 10.4088/Jcp.20M13229  0.48
2020 Shakeel MK, MacQueen G, Addington J, Metzak PD, Georgopoulos G, Bray S, Goldstein BI, MacIntosh BJ, Wang J, Kennedy SH, Lebel C. White Matter Connectivity in Youth at Risk for Serious Mental Illness: A Longitudinal Analysis. Psychiatry Research. Neuroimaging. 302: 111106. PMID 32505905 DOI: 10.1016/J.Pscychresns.2020.111106  0.48
2020 Farris MS, Shakeel MK, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Substance use in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 32500614 DOI: 10.1111/Eip.12995  0.48
2020 Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R, Moazamigoudarzi Z, Placenza FM, Richard-Devantoy S, Rotzinger S, Turecki G, ... ... Kennedy SH, et al. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. Bmc Psychiatry. 20: 268. PMID 32487236 DOI: 10.1186/S12888-020-02672-3  0.32
2020 Dunlop K, Rizvi SJ, Kennedy SH, Hassel S, Strother SC, Harris JK, Zamyadi M, Arnott SR, Davis AD, Mansouri F, Schulze L, Ceniti AK, Lam RW, Milev R, Rotzinger S, et al. Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32349119 DOI: 10.1038/S41386-020-0688-X  0.44
2020 Suh JS, Minuzzi L, Raamana PR, Davis A, Hall GB, Harris J, Hassel S, Zamyadi M, Arnott SR, Alders GL, Sassi RB, Milev R, Lam RW, MacQueen GM, Strother SC, ... Kennedy SH, et al. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report. Neuroimage. Clinical. 25: 102178. PMID 32036277 DOI: 10.1016/J.Nicl.2020.102178  0.44
2020 Nogovitsyn N, Souza R, Muller M, Srajer A, Metzak PD, Hassel S, Ismail Z, Protzner A, Bray SL, Lebel C, MacIntosh BJ, Goldstein BI, Wang J, Kennedy SH, Addington J, et al. Aberrant limbic brain structures in young individuals at risk for mental illness. Psychiatry and Clinical Neurosciences. PMID 32003517 DOI: 10.1111/Pcn.12985  0.44
2020 Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Personality and risk for serious mental illness. Early Intervention in Psychiatry. PMID 31910491 DOI: 10.1111/Eip.12921  0.48
2020 Zhdanov A, Atluri S, Wong W, Vaghei Y, Daskalakis ZJ, Blumberger DM, Frey BN, Giacobbe P, Lam RW, Milev R, Mueller DJ, Turecki G, Parikh SV, Rotzinger S, Soares CN, ... ... Kennedy SH, et al. Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression. Jama Network Open. 3: e1918377. PMID 31899530 DOI: 10.1001/jamanetworkopen.2019.18377  0.32
2020 Stowkowy J, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Trauma in Youth At-Risk for Serious Mental Illness. The Journal of Nervous and Mental Disease. 208: 70-76. PMID 31834192 DOI: 10.1097/Nmd.0000000000001069  0.48
2019 Daniels S, Horman T, Lapointe T, Melanson B, Storace A, Kennedy SH, Frey BN, Rizvi SJ, Hassel S, Mueller DJ, Parikh SV, Lam RW, Blier P, Farzan F, Giacobbe P, et al. Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers. Journal of Affective Disorders. 263: 353-366. PMID 31969265 DOI: 10.1016/J.Jad.2019.11.108  0.32
2019 Yrondi A, Fiori LM, Frey BN, Lam RW, MacQueen GM, Milev R, Müller DJ, Foster JA, Kennedy SH, Turecki G. Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN-BIND-1 report. The International Journal of Neuropsychopharmacology. PMID 31819986 DOI: 10.1093/Ijnp/Pyz066  0.44
2019 Hassel S, Sharma GB, Alders GL, Davis AD, Arnott SR, Frey BN, Hall GB, Harris JK, Lam RW, Milev R, Müller DJ, Rotzinger S, Zamyadi M, Kennedy SH, Strother SC, et al. Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants. Human Brain Mapping. PMID 31794150 DOI: 10.1002/Hbm.24883  0.44
2019 Alders GL, Davis AD, MacQueen G, Strother SC, Hassel S, Zamyadi M, Sharma GB, Arnott SR, Downar J, Harris JK, Lam RW, Milev R, Müller DJ, Ravindran A, Kennedy SH, et al. Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study. Journal of Affective Disorders. PMID 31757619 DOI: 10.1016/J.Jad.2019.11.068  0.48
2019 Fonseka TM, Pong JT, Kcomt A, Kennedy SH, Parikh SV. Collaborating with individuals with lived experience to adapt CANMAT clinical depression guidelines into a patient treatment guide: The CHOICE-D co-design process. Journal of Evaluation in Clinical Practice. PMID 31729117 DOI: 10.1111/Jep.13308  0.44
2019 Stowkowy J, Brummitt K, Bonneville D, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, MacQueen G, Addington J. Sleep disturbances in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 31724327 DOI: 10.1111/Eip.12898  0.48
2019 Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, ... ... Kennedy SH, et al. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31610545 DOI: 10.1038/S41386-019-0542-1  0.44
2019 Ju C, Fiori LM, Belzeaux R, Theroux JF, Chen GG, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, ... ... Kennedy SH, et al. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9: 254. PMID 31594917 DOI: 10.1038/S41398-019-0589-0  0.44
2019 Chakrabarty T, Harkness KL, McInerney SJ, Quilty LC, Milev RV, Kennedy SH, Frey BN, MacQueen GM, Müller DJ, Rotzinger S, Uher R, Lam RW. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 1-12. PMID 31583989 DOI: 10.1017/S003329171900268X  0.44
2019 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Social and role functioning in youth at risk of serious mental illness. Early Intervention in Psychiatry. PMID 31502422 DOI: 10.1111/Eip.12872  0.48
2019 Davis AD, Hassel S, Arnott SR, Harris J, Lam RW, Milev R, Rotzinger S, Zamyadi M, Frey BN, Minuzzi L, Strother SC, MacQueen GM, Kennedy SH, Hall GB. White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471185 DOI: 10.1016/J.Bpsc.2019.05.016  0.44
2019 Alders GL, Davis AD, MacQueen G, Strother SC, Hassel S, Zamyadi M, Sharma GB, Arnott SR, Downar J, Harris JK, Lam RW, Milev R, Müller DJ, Ravindran A, Kennedy SH, et al. Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study. Journal of Affective Disorders. 257: 765-773. PMID 31400735 DOI: 10.1016/J.Jad.2019.07.037  0.48
2019 Fonseka TM, Bhat V, Kennedy SH. The utility of artificial intelligence in suicide risk prediction and the management of suicidal behaviors. The Australian and New Zealand Journal of Psychiatry. 4867419864428. PMID 31347389 DOI: 10.1177/0004867419864428  0.44
2019 Murphy JK, Michalak EE, Colquhoun H, Woo C, Ng CH, Parikh SV, Culpepper L, Dewa CS, Greenshaw AJ, He Y, Kennedy SH, Li XM, Liu T, Soares CN, Wang Z, et al. Methodological approaches to situational analysis in global mental health: a scoping review. Global Mental Health (Cambridge, England). 6: e11. PMID 31258925 DOI: 10.1017/gmh.2019.9  0.32
2019 Belzeaux R, Fiori LM, Lopez JP, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, ... ... Kennedy SH, et al. Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. The Journal of Clinical Psychiatry. 80. PMID 31087825 DOI: 10.4088/Jcp.18M12556  0.44
2019 Nogovitsyn N, Souza R, Muller M, Srajer A, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Bray SL, Lebel C, Addington JM, ... ... Kennedy SH, et al. Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. Neuroimage. PMID 31075395 DOI: 10.1016/J.Neuroimage.2019.05.017  0.44
2019 Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, et al. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 80. PMID 30840787 DOI: 10.4088/Jcp.18M12202  0.44
2019 MacQueen GM, Hassel S, Arnott SR, Jean A, Bowie CR, Bray SL, Davis AD, Downar J, Foster JA, Frey BN, Goldstein BI, Hall GB, Harkness KL, Harris J, Lam RW, ... ... Kennedy SH, et al. The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols Journal of Psychiatry & Neuroscience : Jpn. 44: 1-14. PMID 30840428 DOI: 10.1503/Jpn.180036  0.44
2019 Addington J, Liu L, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Stowkowy J, MacQueen G. Clinical staging for youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 30672153 DOI: 10.1111/Eip.12786  0.48
2019 Islam F, Marshe V, Maciukiewicz M, Lam R, MacQueen G, Frey B, Milev R, Parikh S, Soares C, Uher R, Turecki G, Rotzinger S, Foster JA, Kennedy S, Mueller D. M31 Impact Of Cyp2C19 And Cyp2D6 Gene Variants On Plasma Levels And Treatment Response In Patients Receiving Escitalopram And Aripiprazole For Major Depression: Results From The Can-Bind-1 Cohort European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.131  0.48
2019 Islam F, Marshe V, Maciukiewicz M, Yoshida K, Lam RW, MacQueen G, Frey BN, Milev R, Parikh S, Soares C, Uher R, Turecki G, Rotzinger S, Foster J, Kennedy SH, et al. S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.875  0.48
2019 Desjardins C, Nogovitsyn N, Souza R, Hassel S, Arnott S, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Bray S, Lebel C, Addington J, Milev R, Harkness K, ... ... Kennedy SH, et al. F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.650  0.44
2018 Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Parikh SV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Focus (American Psychiatric Publishing). 16: 85-94. PMID 32015703 DOI: 10.1176/appi.focus.16106  0.44
2018 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Neurocognitive deficits in a transdiagnostic clinical staging model. Psychiatry Research. PMID 30360915 DOI: 10.1016/J.Psychres.2018.10.030  0.48
2018 Allen TA, Lam RW, Milev R, Rizvi SJ, Frey BN, MacQueen GM, Müller DJ, Uher R, Kennedy SH, Quilty LC. Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 1-10. PMID 30220263 DOI: 10.1017/S0033291718002441  0.44
2018 Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Family functioning in youth at-risk for serious mental illness. Comprehensive Psychiatry. 87: 17-24. PMID 30193153 DOI: 10.1016/J.Comppsych.2018.08.010  0.48
2018 Suh JS, Schneider MA, Minuzzi L, MacQueen GM, Strother SC, Kennedy SH, Frey BN. Cortical thickness in major depressive disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30118825 DOI: 10.1016/J.Pnpbp.2018.08.008  0.44
2018 Farris MS, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Treatment History of Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718792195. PMID 30071747 DOI: 10.1177/0706743718792195  0.48
2018 Addington J, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, Hassel S, Marshall C, MacQueen G. Youth at-risk for serious mental illness: methods of the PROCAN study. Bmc Psychiatry. 18: 219. PMID 29976184 DOI: 10.1186/S12888-018-1801-0  0.48
2018 Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. PMID 29536616 DOI: 10.1111/Bdi.12609  0.48
2018 McInerney S, Frey BN, Milev R, Chakrabarty T, Woo C, Kennedy SH, Lam RW. S120. Canadian Biomarker Integration Network in Depression (CAN-BIND): Baseline and Follow up Neurocognitive Mediators of Functioning in Major Depressive Disorder (MDD) Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1011  0.32
2017 Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, Pat McAndrews M, Blier P, Evans K, Foster JA, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Müller DJ, ... ... Kennedy SH, et al. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. Journal of Affective Disorders. 227: 542-549. PMID 29169123 DOI: 10.1016/J.Jad.2017.10.028  0.44
2017 Fonseka TM, MacQueen GM, Kennedy SH. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder. Journal of Affective Disorders. PMID 29150145 DOI: 10.1016/J.Jad.2017.10.049  0.44
2017 Farzan F, Atluri S, Frehlich M, Dhami P, Kleffner K, Price R, Lam RW, Frey BN, Milev R, Ravindran A, McAndrews MP, Wong W, Blumberger D, Daskalakis ZJ, Vila-Rodriguez F, ... ... Kennedy SH, et al. Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression. Scientific Reports. 7: 7473. PMID 28785082 DOI: 10.1038/S41598-017-07613-X  0.32
2017 Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Kennedy JL, Rotzinger S, Foster JA, Kennedy SH, Müller DJ. Genome-wide association studies of placebo and duloxetine response in major depressive disorder. The Pharmacogenomics Journal. PMID 28696415 DOI: 10.1038/Tpj.2017.29  0.44
2017 Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, ... ... Kennedy SH, et al. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8: 15497. PMID 28530238 DOI: 10.1038/Ncomms15497  0.44
2017 Lam RW, Ismail Z, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, Kennedy SH. Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 62: 353-354. PMID 28525728 DOI: 10.1177/0706743717700878  0.44
2017 Parikh SV, Quilty L, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Uher R, Kennedy SH, Lam RW, MacQueen GM, Milev R, Ravindran AV. Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 62: 77-78. PMID 28055254 DOI: 10.1177/0706743716676754  0.44
2016 Cha DS, Best MW, Bowie CR, Gallaugher LA, Woldeyohannes HO, Soczynska JK, Lewis G, MacQueen G, Sahakian BJ, Kennedy SH, Lui JP, Mansur RB, McIntyre RS. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder. Journal of Affective Disorders. 210: 57-65. PMID 28013123 DOI: 10.1016/J.Jad.2016.12.006  0.48
2016 Vaccarino AL, Evans KR, Kalali AH, Kennedy SH, Engelhardt N, Frey BN, Greist JH, Kobak KA, Lam RW, MacQueen G, Milev R, Placenza FM, Ravindran AV, Sheehan DV, Sills T, et al. The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder. Innovations in Clinical Neuroscience. 13: 20-31. PMID 27974997  0.48
2016 Mak LE, Minuzzi L, MacQueen G, Hall G, Kennedy S, Milev R. The Default Mode Network in Healthy Individuals: A Systematic Review and Meta-Analysis. Brain Connectivity. PMID 27917679 DOI: 10.1089/Brain.2016.0438  0.48
2016 Zhou AJ, Lee Y, Salvadore G, Hsu B, Fonseka TM, Kennedy SH, McIntyre RS. Sirukumab: A Potential Treatment for Mood Disorders? Advances in Therapy. PMID 27913990 DOI: 10.1007/S12325-016-0455-X  0.44
2016 Habert J, Katzman MA, Oluboka OJ, McIntyre RS, McIntosh D, MacQueen GM, Khullar A, Milev RV, Kjernisted KD, Chokka PR, Kennedy SH. Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment. The Primary Care Companion For Cns Disorders. 18. PMID 27835721 DOI: 10.4088/Pcc.15R01926  0.44
2016 Fonseka TM, Müller DJ, Kennedy SH. Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications. Molecular Neuropsychiatry. 2: 1-14. PMID 27606316 DOI: 10.1159/000441521  0.44
2016 Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, Modirrousta M, Patry S, Vila-Rodriguez F, Lam RW, MacQueen GM, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486154 DOI: 10.1177/0706743716660033  0.48
2016 Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Parikh SV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486153 DOI: 10.1177/0706743716660290  0.48
2016 Lam RW, Kennedy SH, Parikh SV, MacQueen GM, Milev RV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486152 DOI: 10.1177/0706743716659061  0.44
2016 Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song WY, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486151 DOI: 10.1177/0706743716659416  0.48
2016 Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Ravindran AV, Uher R. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486150 DOI: 10.1177/0706743716659418  0.44
2016 MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Van Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486149 DOI: 10.1177/0706743716659276  0.44
2016 Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486148 DOI: 10.1177/0706743716659417  0.48
2016 Nowrouzi B, McIntyre RS, MacQueen G, Kennedy SH, Kennedy JL, Ravindran A, Yatham L, De Luca V. Admixture analysis of age at onset in first episode bipolar disorder. Journal of Affective Disorders. 201: 88-94. PMID 27182964 DOI: 10.1016/J.Jad.2016.04.006  0.48
2016 Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Geraci J, Giacobbe P, ... ... Kennedy SH, et al. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. Bmc Psychiatry. 16: 105. PMID 27084692 DOI: 10.1186/S12888-016-0785-X  0.48
2016 Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH. Assessing anhedonia in depression: Potentials and pitfalls. Neuroscience and Biobehavioral Reviews. PMID 26959336 DOI: 10.1016/J.Neubiorev.2016.03.004  0.48
2016 Fonseka TM, Wen XY, Foster JA, Kennedy SH. Zebrafish models of major depressive disorders. Journal of Neuroscience Research. 94: 3-14. PMID 26452974 DOI: 10.1002/Jnr.23639  0.48
2015 McIntyre RS, Woldeyohannes HO, Soczynska JK, Maruschak NA, Wium-Andersen IK, Vinberg M, Cha DS, Lee Y, Xiao HX, Gallaugher LA, Dale RM, Alsuwaidan MT, Mansur RB, Muzina DJ, Carvalho AF, ... ... Kennedy SH, et al. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project. Cns Spectrums. 1-5. PMID 26714651 DOI: 10.1017/S1092852915000747  0.48
2015 Kennedy SH, Avedisova A, Belaïdi C, Picarel-Blanchot F, de Bodinat C. Sustained efficacy of agomelatine 10mg, 25mg, and 25-50mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26708320 DOI: 10.1016/J.Euroneuro.2015.09.006  0.48
2015 Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Rotzinger S, Foster JA, Kennedy JL, Kennedy SH, Müller DJ. Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder. Pharmacogenomics. PMID 26556688 DOI: 10.2217/Pgs.15.136  0.48
2015 Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Cristea IA, Faramarzi M, Hegerl U, Jarrett RB, Kheirkhah F, Kennedy SH, et al. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis. Jama Psychiatry. PMID 26397232 DOI: 10.1001/Jamapsychiatry.2015.1516  0.48
2015 Rizvi SJ, Sproule BA, Gallaugher L, McIntyre RS, Kennedy SH. Correlates of benzodiazepine use in major depressive disorder: The effect of anhedonia. Journal of Affective Disorders. 187: 101-5. PMID 26331683 DOI: 10.1016/J.Jad.2015.07.040  0.48
2015 Dunlop K, Gaprielian P, Blumberger D, Daskalakis ZJ, Kennedy SH, Giacobbe P, Downar J. MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder. Journal of Visualized Experiments : Jove. e53129. PMID 26327307 DOI: 10.3791/53129  0.48
2015 Rizvi SJ, Quilty LC, Sproule BA, Cyriac A, Michael Bagby R, Kennedy SH. Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression. Psychiatry Research. 229: 109-19. PMID 26250147 DOI: 10.1016/J.Psychres.2015.07.062  0.48
2015 Sun Y, Giacobbe P, Tang CW, Barr MS, Rajji T, Kennedy SH, Fitzgerald PB, Lozano AM, Wong W, Daskalakis ZJ. Deep Brain Stimulation Modulates Gamma Oscillations and Theta-Gamma Coupling in Treatment Resistant Depression. Brain Stimulation. PMID 26195320 DOI: 10.1016/J.Brs.2015.06.010  0.48
2015 Fonseka TM, McIntyre RS, Soczynska JK, Kennedy SH. Evidence to support peripheral and central IL-6 signaling targets to treat depression. Expert Opinion On Investigational Drugs. 24: 991-2. PMID 26082086 DOI: 10.1517/13543784.2015.1057675  0.48
2015 Lam RW, Kennedy SH. STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby! Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 6-8. PMID 25886543 DOI: 10.1177/070674371506000103  0.48
2015 Fonseka TM, McIntyre RS, Soczynska JK, Kennedy SH. Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opinion On Investigational Drugs. 24: 459-75. PMID 25585966 DOI: 10.1517/13543784.2014.998334  0.48
2015 Srejic LR, Prescott IA, Zhang P, Strauss I, Dostrovsky JO, Giacobbe P, Kennedy SH, Lozano AM, Hamani C, Hutchison WD. Paired Pulse Depression in the Subcallosal Cingulate Region of Depression Patients. Biological Psychiatry. 78: e3-4. PMID 25582268 DOI: 10.1016/J.Biopsych.2014.09.018  0.48
2015 Fonseka TM, Tiwari AK, Gonçalves VF, Lieberman JA, Meltzer HY, Goldstein BI, Kennedy JL, Kennedy SH, Müller DJ. The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 16: 45-56. PMID 25560300 DOI: 10.3109/15622975.2014.984631  0.48
2015 Bakker N, Shahab S, Giacobbe P, Blumberger DM, Daskalakis ZJ, Kennedy SH, Downar J. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain Stimulation. 8: 208-15. PMID 25465290 DOI: 10.1016/J.Brs.2014.11.002  0.48
2015 McIntyre RS, Soczynska JZ, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Carvalho AF, Jerrell JM, Dale RM, Gallaugher LA, Muzina DJ, Kennedy SH. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Comprehensive Psychiatry. 56: 279-82. PMID 25439523 DOI: 10.1016/J.Comppsych.2014.08.051  0.48
2014 Lam RW, Kennedy SH, Mclntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 649-54. PMID 25702365 DOI: 10.1177/070674371405901206  0.48
2014 McIntyre RS, Soczynska JK, Cha DS, Woldeyohannes HO, Dale RS, Alsuwaidan MT, Gallaugher LA, Mansur RB, Muzina DJ, Carvalho A, Kennedy SH. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project. Journal of Affective Disorders. 172: 259-264. PMID 25451425 DOI: 10.1016/J.Jad.2014.09.026  0.48
2014 Cuijpers P, Weitz E, Twisk J, Kuehner C, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Jarrett RB, Kennedy SH, Kheirkhah F, Mergl R, et al. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis. Depression and Anxiety. 31: 941-51. PMID 25407584 DOI: 10.1002/Da.22328  0.48
2014 Rizvi SJ, Geraci J, Ravindran A, Kennedy SH. Predictors of response to adjunctive osmotic-release methylphenidate or placebo in patients with major depressive disorder: effects of apathy/anhedonia and fatigue. Journal of Clinical Psychopharmacology. 34: 755-9. PMID 25203470 DOI: 10.1097/Jcp.0000000000000211  0.48
2014 Kennedy SH, Giacobbe P, Placenza F, Hudson CJ, Seeman P, Seeman MV. Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study Journal of Affective Disorders. 166: 139-143. PMID 25012422 DOI: 10.1016/J.Jad.2014.04.014  0.48
2014 Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, Bakker N, Blumberger DM, Daskalakis ZJ, Kennedy SH, Flint AJ, Giacobbe P. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biological Psychiatry. 76: 176-85. PMID 24388670 DOI: 10.1016/J.Biopsych.2013.10.026  0.48
2014 Quraan MA, Protzner AB, Daskalakis ZJ, Giacobbe P, Tang CW, Kennedy SH, Lozano AM, McAndrews MP. EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1270-81. PMID 24285211 DOI: 10.1038/Npp.2013.330  0.48
2014 Salomons TV, Dunlop K, Kennedy SH, Flint A, Geraci J, Giacobbe P, Downar J. Resting-state cortico-thalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 488-98. PMID 24150516 DOI: 10.1038/Npp.2013.222  0.48
2014 Lipsman N, Sankar T, Downar J, Kennedy SH, Lozano AM, Giacobbe P. Neuromodulation for treatment-refractory major depressive disorder. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 186: 33-9. PMID 23897945 DOI: 10.1503/Cmaj.121317  0.48
2014 Kennedy SH, Avedisova A, Giménez-Montesinos N, Belaïdi C, Christian de B, Corral RM, Caches MA, Lamaison HF, Gargoloff PR, Lupo C, Finkelsztein C, Berardo GM, Mosca D, Serfaty EM, Kuper E, et al. A placebo-controlled study of three agomelatine dose regimens (10mg, 25mg, 25-50mg) in patients with major depressive disorder European Neuropsychopharmacology. 24: 553-563. DOI: 10.1016/J.Euroneuro.2014.01.006  0.48
2013 Lam RW, Parikh SV, Ramasubbu R, Michalak EE, Tam EM, Axler A, Yatham LN, Kennedy SH, Manjunath CV. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 203: 358-65. PMID 24029535 DOI: 10.1192/Bjp.Bp.112.125237  0.48
2013 McIntyre RS, Alsuwaidan M, Soczynska JK, Szpindel I, Bilkey TS, Almagor D, Woldeyohannes HO, Powell AM, Cha DS, Gallaugher LA, Kennedy SH. The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder Human Psychopharmacology. 28: 421-427. PMID 24014142 DOI: 10.1002/Hup.2325  0.48
2013 Rizvi SJ, Salomons TV, Konarski JZ, Downar J, Giacobbe P, McIntyre RS, Kennedy SH. Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation. Journal of Affective Disorders. 151: 573-81. PMID 23948629 DOI: 10.1016/J.Jad.2013.06.050  0.48
2013 Leen J, Soczynska JK, Gallaugher LA, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Dale RM, Muzina DJ, Kennedy SH, McIntyre RS. The effect of personality dimensions on functional outcomes in mood disorders. Advances in Therapy. 30: 671-83. PMID 23839119 DOI: 10.1007/S12325-013-0042-3  0.48
2013 Schaffer A, Parikh SV, Kennedy SH, Milev R, Frey BN, Goldstein BI, Beaulieu S, Alda M, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Bond DJ, et al. Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines. Bipolar Disorders. 15: 338-9. PMID 23521579 DOI: 10.1111/Bdi.12055  0.48
2013 Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, et al. The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disorders. 15: 58-60. PMID 23339676 DOI: 10.1111/Bdi.12038  0.48
2013 Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders. 15: 1-44. PMID 23237061 DOI: 10.1111/Bdi.12025  0.48
2013 Kennedy SH, Placenza FM. Agomelatine in depressive disorders Melatonin and Melatonergic Drugs in Clinical Practice. 275-279. DOI: 10.1007/978-81-322-0825-9_19  0.48
2012 Hamani C, Giacobbe P, Diwan M, Balbino ES, Tong J, Bridgman A, Lipsman N, Lozano AM, Kennedy SH, Nobrega JN. Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation. The American Journal of Psychiatry. 169: 1320-1. PMID 23212066 DOI: 10.1176/Appi.Ajp.2012.12060754  0.48
2012 McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Vaccarino A, Macqueen G, Lewis GF, Kennedy SH. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. Bipolar Disorders. 14: 697-706. PMID 23107220 DOI: 10.1111/Bdi.12006  0.48
2012 Soczynska JK, Mansur RB, Brietzke E, Swardfager W, Kennedy SH, Woldeyohannes HO, Powell AM, Manierka MS, McIntyre RS. Novel therapeutic targets in depression: Minocycline as a candidate treatment Behavioural Brain Research. 235: 302-317. PMID 22963995 DOI: 10.1016/J.Bbr.2012.07.026  0.48
2012 Parikh SV, Zaretsky A, Beaulieu S, Yatham LN, Young LT, Patelis-Siotis I, Macqueen GM, Levitt A, Arenovich T, Cervantes P, Velyvis V, Kennedy SH, Streiner DL. A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. The Journal of Clinical Psychiatry. 73: 803-10. PMID 22795205 DOI: 10.4088/Jcp.11M07343  0.48
2012 Kennedy SH, Downar J, Evans KR, Feilotter H, Lam RW, MacQueen GM, Milev R, Parikh SV, Rotzinger S, Soares C. The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Current Pharmaceutical Design. 18: 5976-89. PMID 22681173 DOI: 10.2174/138161212803523635  0.48
2012 Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT, Debonnel G, Sadikot AF, Lam RW, Howard AK, Ilcewicz-Klimek M, Honey CR, Mayberg HS. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. Journal of Neurosurgery. 116: 315-22. PMID 22098195 DOI: 10.3171/2011.10.Jns102122  0.48
2011 Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH. Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation International Review of Psychiatry. 23: 424-436. PMID 22200132 DOI: 10.3109/09540261.2011.630993  0.48
2011 Czira ME, Lindner AV, Szeifert L, Molnar MZ, Fornadi K, Kelemen A, Laszlo G, Mucsi I, Keszei AP, Kennedy SH, Novak M. Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. General Hospital Psychiatry. 33: 157-65. PMID 21596209 DOI: 10.1016/J.Genhosppsych.2011.01.012  0.48
2011 Morehouse R, Macqueen G, Kennedy SH. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. Journal of Affective Disorders. 132: S14-20. PMID 21575992 DOI: 10.1016/J.Jad.2011.03.047  0.48
2011 Kennedy SH, Young AH, Blier P. Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets. Journal of Affective Disorders. 132: S21-8. PMID 21571374 DOI: 10.1016/J.Jad.2011.03.048  0.48
2011 Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Lindner A, Fornadi K, Kiss I, Remport A, Novak M, Kennedy SH, Rosivall L, Kovesdy CP, Mucsi I. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 58: 101-8. PMID 21316133 DOI: 10.1053/J.Ajkd.2010.11.027  0.48
2011 Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS, Lozano AM. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. The American Journal of Psychiatry. 168: 502-10. PMID 21285143 DOI: 10.1176/Appi.Ajp.2010.10081187  0.48
2011 Rizvi SJ, Yeung NW, Kennedy SH. Instruments to measure sexual dysfunction in community and psychiatric populations. Journal of Psychosomatic Research. 70: 99-109. PMID 21193105 DOI: 10.1016/J.Jpsychores.2010.05.009  0.48
2010 Lipsman N, McIntyre RS, Giacobbe P, Torres C, Kennedy SH, Lozano AM. Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targets. Bipolar Disorders. 12: 691-701. PMID 21040286 DOI: 10.1111/J.1399-5618.2010.00868.X  0.48
2010 McIntyre RS, Kennedy SH, Soczynska JK, Nguyen HT, Bilkey TS, Woldeyohannes HO, Nathanson JA, Joshi S, Cheng JS, Benson KM, Muzina DJ. Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Primary Care Companion to the Journal of Clinical Psychiatry. 12. PMID 20944770 DOI: 10.4088/Pcc.09M00861Gry  0.48
2010 Pangallo BA, Zhang Q, Desaiah D, Perahia DG, Detke MJ, Kennedy SH. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials. Current Medical Research and Opinion. 26: 2643-51. PMID 20932222 DOI: 10.1185/03007995.2010.522157  0.48
2010 McIntyre RS, Woldeyohannes HO, Soczynska JK, Miranda A, Lachowski A, Liauw SS, Grossman T, Lourenco MT, Kim B, Alsuwaidan MT, Kennedy SH. The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder. Advances in Therapy. 27: 828-36. PMID 20878373 DOI: 10.1007/S12325-010-0072-Z  0.48
2010 Kennedy SH, Welsh BR, Fulton K, Soczynska JK, McIntyre RS, O'Donovan C, Milev R, le Melledo JM, Bisserbe JC, Zimmerman M, Martin N. Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 568-76. PMID 20840804 DOI: 10.1177/070674371005500905  0.48
2010 McIntyre RS, Park KY, Law CW, Sultan F, Adams A, Lourenco MT, Lo AK, Soczynska JK, Woldeyohannes H, Alsuwaidan M, Yoon J, Kennedy SH. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. Cns Drugs. 24: 741-53. PMID 20806987 DOI: 10.2165/11533280-000000000-00000  0.48
2010 McIntyre RS, Kenna HA, Nguyen HT, Law CW, Sultan F, Woldeyohannes HO, Adams AK, Cheng JS, Lourenco M, Kennedy SH, Rasgon NL. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? Advances in Therapy. 27: 63-80. PMID 20390390 DOI: 10.1007/S12325-010-0011-Z  0.48
2010 Giacobbe P, Lipsman N, Hamani C, Lozano AM, Kennedy SH. Subgenual Cingulate Gyrus deep brain stimulation: Current status and future directions Psychiatric Annals. 40: 485-491. DOI: 10.3928/00485713-20100924-07  0.48
2009 Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. Journal of Affective Disorders. 117: S1-2. PMID 19682750 DOI: 10.1016/J.Jad.2009.06.043  0.48
2009 Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, Patten SB. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. Journal of Affective Disorders. 117: S15-25. PMID 19682749 DOI: 10.1016/J.Jad.2009.06.042  0.48
2009 Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. Journal of Affective Disorders. 117: S5-14. PMID 19674796 DOI: 10.1016/J.Jad.2009.06.044  0.48
2009 Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. Journal of Affective Disorders. 117: S26-43. PMID 19674794 DOI: 10.1016/J.Jad.2009.06.041  0.48
2009 Ravindran AV, Lam RW, Filteau MJ, Lespérance F, Kennedy SH, Parikh SV, Patten SB. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. Journal of Affective Disorders. 117: S54-64. PMID 19666194 DOI: 10.1016/J.Jad.2009.06.040  0.48
2009 Kennedy SH, Milev R, Giacobbe P, Ramasubbu R, Lam RW, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. Journal of Affective Disorders. 117: S44-53. PMID 19656575 DOI: 10.1016/J.Jad.2009.06.039  0.48
2009 Hamani C, Mayberg H, Snyder B, Giacobbe P, Kennedy S, Lozano AM. Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting. Journal of Neurosurgery. 111: 1209-15. PMID 19480538 DOI: 10.3171/2008.10.Jns08763  0.48
2009 Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression? Neurotoxicology. 30: 497-521. PMID 19477018 DOI: 10.1016/J.Neuro.2009.03.004  0.44
2009 Levitan RD, Atkinson L, Pedersen R, Buis T, Kennedy SH, Chopra K, Leung EM, Segal ZV. A novel examination of atypical major depressive disorder based on attachment theory. The Journal of Clinical Psychiatry. 70: 879-87. PMID 19422755 DOI: 10.4088/Jcp.07M03306  0.48
2009 Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders. 11: 225-55. PMID 19419382 DOI: 10.1111/J.1399-5618.2009.00672.X  0.48
2009 Levitan RD, Atkinson L, Pedersen R, Buis T, Kennedy SH, Chopra K, Leung EM, Segal ZV. Dr Levitan and colleagues reply Journal of Clinical Psychiatry. 70: 1726. DOI: 10.4088/Jcp.09Lr05363A  0.48
2009 Ravindran AV, Kennedy SH, Binder CE. Dr. Ravindran and colleagues reply Journal of Clinical Psychiatry. 70: 433-434. DOI: 10.4088/Jcp.08Lr04686A  0.48
2008 Chopra KK, Segal ZV, Buis T, Kennedy SH, Levitan RD. Investigating associations between cortisol and cognitive reactivity to sad mood provocation and the prediction of relapse in remitted major depression. Asian Journal of Psychiatry. 1: 33-6. PMID 23050993 DOI: 10.1016/J.Ajp.2008.09.006  0.48
2008 Giacobbe P, Mcintyre RS, Goldstein BI, Kennedy SH, Flint AJ. Rates and patterns of treatment seeking by individuals with mood and anxiety disorders. Psychiatric Services. 59: 1099-1099. PMID 18832492 DOI: 10.1176/Appi.Ps.59.10.1099  0.44
2008 Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry. 64: 461-7. PMID 18639234 DOI: 10.1016/j.biopsych.2008.05.034  0.48
2008 Bagby RM, Quilty LC, Segal ZV, McBride CC, Kennedy SH, Costa PT. Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 53: 361-70. PMID 18616856 DOI: 10.1177/070674370805300605  0.48
2008 Neimat JS, Hamani C, Giacobbe P, Merskey H, Kennedy SH, Mayberg HS, Lozano AM. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. The American Journal of Psychiatry. 165: 687-93. PMID 18519534 DOI: 10.1176/Appi.Ajp.2008.07081298  0.48
2008 McNeely HE, Mayberg HS, Lozano AM, Kennedy SH. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. The Journal of Nervous and Mental Disease. 196: 405-10. PMID 18477883 DOI: 10.1097/Nmd.0B013E3181710927  0.48
2008 Ravindran AV, Kennedy SH, O'Donovan MC, Fallu A, Camacho F, Binder CE. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. The Journal of Clinical Psychiatry. 69: 87-94. PMID 18312042 DOI: 10.4088/Jcp.V69N0112  0.48
2007 McIntyre RS, Soczynska JK, Woldeyohannes HO, Lewis GF, Leiter LA, MacQueen GM, Miranda A, Fulgosi D, Konarski JZ, Kennedy SH. Thiazolidinediones: novel treatments for cognitive deficits in mood disorders? Expert Opinion On Pharmacotherapy. 8: 1615-28. PMID 17685880 DOI: 10.1517/14656566.8.11.1615  0.48
2007 Konarski JZ, Kennedy SH, McIntyre RS, Rafi-Tari S, Soczynska JK, Mayberg HS. Relationship between regional brain metabolism, illness severity and age in depressed subjects. Psychiatry Research. 155: 203-10. PMID 17574393 DOI: 10.1016/J.Pscychresns.2007.02.001  0.48
2007 McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Current Opinion in Psychiatry. 20: 406-16. PMID 17551358 DOI: 10.1097/Yco.0B013E3281938102  0.48
2007 Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. The American Journal of Psychiatry. 164: 778-88. PMID 17475737 DOI: 10.1176/Appi.Ajp.164.5.778  0.48
2007 Castel S, Rush B, Kennedy S, Fulton K, Toneatto T. Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a self-assessment instrument. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 22-7. PMID 17444075 DOI: 10.1177/070674370705200105  0.48
2006 Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders. 8: 721-39. PMID 17156158 DOI: 10.1111/J.1399-5618.2006.00432.X  0.48
2006 McIntyre RS, Soczynska JK, Lewis GF, MacQueen GM, Konarski JZ, Kennedy SH. Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opinion On Pharmacotherapy. 7: 1305-21. PMID 16805717 DOI: 10.1517/14656566.7.10.1305  0.48
2006 Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S. Sexual function during bupropion or paroxetine treatment of major depressive disorder Canadian Journal of Psychiatry. 51: 234-242. PMID 16629348 DOI: 10.1177/070674370605100405  0.48
2005 Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders. 7: 5-69. PMID 15952957 DOI: 10.1111/J.1399-5618.2005.00219.X  0.48
2005 Chopra KK, Bagby RM, Dickens S, Kennedy SH, Ravindran A, Levitan RD. A dimensional approach to personality in atypical depression. Psychiatry Research. 134: 161-7. PMID 15840417 DOI: 10.1016/J.Psychres.2005.02.002  0.48
2005 Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 45: 651-60. PMID 15748841 DOI: 10.1016/J.Neuron.2005.02.014  0.48
2004 Levitan RD, Masellis M, Basile VS, Lam RW, Kaplan AS, Davis C, Muglia P, Mackenzie B, Tharmalingam S, Kennedy SH, Macciardi F, Kennedy JL. The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biological Psychiatry. 56: 665-9. PMID 15522250 DOI: 10.1016/J.Biopsych.2004.08.013  0.48
2004 Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage. 22: 409-18. PMID 15110034 DOI: 10.1016/J.Neuroimage.2004.01.015  0.48
2004 Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry. 61: 34-41. PMID 14706942 DOI: 10.1001/Archpsyc.61.1.34  0.48
2004 Levitan RD, Masellis M, Lam RW, Muglia P, Basile VS, Jain U, Kaplan AS, Tharmalingam S, Kennedy SH, Kennedy JL. Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 179-86. PMID 14560322 DOI: 10.1038/Sj.Npp.1300314  0.48
2003 Krüger S, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biological Psychiatry. 54: 1274-83. PMID 14643095 DOI: 10.1016/S0006-3223(03)00691-7  0.48
2003 Kennedy SH, Segal ZV, Cohen NL, Levitan RD, Gemar M, Bagby RM. Lithium carbonate versus cognitive therapy as sequential combination treatment strategies in partial responders to antidepressant medication: an exploratory trial. The Journal of Clinical Psychiatry. 64: 439-44. PMID 12716247 DOI: 10.4088/Jcp.V64N0414  0.48
2002 Levitan RD, Masellis M, Basile VS, Lam RW, Jain U, Kaplan AS, Kennedy SH, Siegel G, Walker ML, Vaccarino FJ, Kennedy JL. Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. Journal of Affective Disorders. 71: 229-33. PMID 12167522 DOI: 10.1016/S0165-0327(01)00372-X  0.48
2002 Knott V, Mahoney C, Kennedy S, Evans K. EEG correlates of acute and chronic paroxetine treatment in depression. Journal of Affective Disorders. 69: 241-9. PMID 12103473 DOI: 10.1016/S0165-0327(01)00308-1  0.48
2002 Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. The Journal of Clinical Psychiatry. 63: 181-6. PMID 11926715 DOI: 10.4088/Jcp.V63N0302  0.48
2001 Meyer JH, Krüger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH. Lower dopamine transporter binding potential in striatum during depression Neuroreport. 12: 4121-4125. PMID 11742250 DOI: 10.1097/00001756-200112210-00052  0.48
2001 Levitan RD, Kaplan AS, Masellis M, Basile VS, Walker ML, Lipson N, Siegel GI, Woodside DB, Macciardi FM, Kennedy SH, Kennedy JL. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biological Psychiatry. 50: 640-3. PMID 11690602 DOI: 10.1016/S0006-3223(01)01201-X  0.48
2001 Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. The American Journal of Psychiatry. 158: 899-905. PMID 11384897 DOI: 10.1176/Appi.Ajp.158.6.899  0.48
2001 McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 46: 273-81. PMID 11320682 DOI: 10.1177/070674370104600308  0.48
2001 Knott V, Mahoney C, Kennedy S, Evans K. EEG power, frequency, asymmetry and coherence in male depression. Psychiatry Research. 106: 123-40. PMID 11306251 DOI: 10.1016/S0925-4927(00)00080-9  0.48
2001 Woodside DB, Garfinkel PE, Lin E, Goering P, Kaplan AS, Goldbloom DS, Kennedy SH. Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community American Journal of Psychiatry. 158: 570-574. PMID 11282690 DOI: 10.1176/Appi.Ajp.158.4.570  0.48
2001 Lai CT, Gordon ES, Kennedy SH, Bateson AN, Coutts RT, Baker GB. Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection Journal of Chromatography B: Biomedical Sciences and Applications. 749: 275-279. PMID 11145064 DOI: 10.1016/S0378-4347(00)00389-3  0.48
2001 Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, DaSilva J, Wilson AA, Rafi-Tari S, Mayberg HS, Kennedy SH. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. The American Journal of Psychiatry. 158: 78-85. PMID 11136637 DOI: 10.1176/Appi.Ajp.158.1.78  0.48
2001 Bagby RM, Gilchrist EJ, Rector NA, Dickens SE, Joffe RT, Levitt A, Levitan RD, Kennedy SH. The stability and validity of the sociotropy and autonomy personality dimensions as measured by the revised personal style inventory Cognitive Therapy and Research. 25: 765-779. DOI: 10.1023/A:1012975524455  0.48
2000 Knott V, Mahoney C, Kennedy S, Evans K. Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry. 33: 201-5. PMID 11147926 DOI: 10.1055/S-2000-8356  0.48
2000 Schaffer A, Levitt AJ, Bagby RM, Kennedy SH, Levitan RD, Joffe RT. Suicidal ideation in major depression: Sex differences and impact of comorbid anxiety Canadian Journal of Psychiatry. 45: 822-826. PMID 11143832 DOI: 10.1177/070674370004500906  0.48
1999 Meyer JH, Cho R, Kennedy S, Kapur S. The effects of single dose nefazodone and paroxetine upon 5-HT(2A) binding potential in humans using [18F]-setoperone PET Psychopharmacology. 144: 279-281. PMID 10435395 DOI: 10.1007/s002130051004  0.48
1999 Parikh SV, Lesage AD, Kennedy SH, Goering PN. Depression in Ontario: Under-treatment and factors related to antidepressant use Journal of Affective Disorders. 52: 67-76. PMID 10357019 DOI: 10.1016/S0165-0327(98)00063-9  0.48
1999 Baker GB, Urichuk LJ, McKenna KF, Kennedy SH. Metabolism of monoamine oxidase inhibitors Cellular and Molecular Neurobiology. 19: 411-426. PMID 10319194 DOI: 10.1023/A:1006901900106  0.48
1999 Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biological Psychiatry. 45: 872-82. PMID 10202575 DOI: 10.1016/S0006-3223(98)00348-5  0.48
1999 Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic International Journal of Eating Disorders. 25: 187-193. PMID 10065396 DOI: 10.1002/(Sici)1098-108X(199903)25:2<187::Aid-Eat8>3.0.Co;2-9  0.48
1999 Bagby RM, Costa PT, McCrae RR, Livesley WJ, Kennedy SH, Levitan RD, Levitt AJ, Joffe RT, Young LT. Replicating the five factor model of personality in a psychiatric sample Personality and Individual Differences. 27: 1135-1139. DOI: 10.1016/S0191-8869(99)00055-0  0.48
1998 Esplen MJ, Garfinkel PE, Olmsted M, Gallop RM, Kennedy S. A randomized controlled trial of guided imagery in bulimia nervosa Psychological Medicine. 28: 1347-1357. PMID 9854276 DOI: 10.1017/S0033291798007405  0.48
1998 Levitan RD, Parikh SV, Lesage AD, Hegadoren KM, Adams M, Kennedy SH, Goering PN. Major depression in individuals with a history of childhood physical or sexual abuse: Relationship to neurovegetative features, mania, and gender American Journal of Psychiatry. 155: 1746-1752. PMID 9842786 DOI: 10.1176/Ajp.155.12.1746  0.48
1998 Levitan RD, Kaplan AS, Brown GM, Vaccarino FJ, Kennedy SH, Levitt AJ, Joffe RT. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder. Archives of General Psychiatry. 55: 244-9. PMID 9510218 DOI: 10.1001/Archpsyc.55.3.244  0.48
1997 Kennedy SH, Javanmard M, Vaccarino FJ. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 42: 467-75. PMID 9220109 DOI: 10.1177/070674379704200502  0.48
1997 Levitan RD, Lesage A, Parikh SV, Goering P, Kennedy SH. Reversed neurovegetative symptoms of depression: A community study of Ontario American Journal of Psychiatry. 154: 934-940. PMID 9210743 DOI: 10.1176/Ajp.154.7.934  0.48
1997 Potts AJ, Bennett PJ, Kennedy SH, Vaccarino FJ. Depressive symptoms and alterations in sucrose taste perception: cognitive bias or a true change in sensitivity? Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Expã©Rimentale. 51: 57-60. PMID 9206323 DOI: 10.1037/1196-1961.51.1.57  0.48
1997 Lambe EK, Katzman DK, Mikulis DJ, Kennedy SH, Zipursky RB. Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Archives of General Psychiatry. 54: 537-42. PMID 9193194 DOI: 10.1001/Archpsyc.1997.01830180055006  0.48
1997 Levitan RD, Kaplan AS, Brown GM, Joffe RT, Levitt AJ, Vaccarino FJ, Kennedy SH. Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression. Biological Psychiatry. 41: 366-8. PMID 9024959 DOI: 10.1016/S0006-3223(96)00432-5  0.48
1996 Garfinkel PE, Lin E, Goering P, Spegg C, Goldbloom DS, Kennedy S, Kaplan AS, Woodside DB. Purging and nonpurging forms of bulimia nervosa in a community sample International Journal of Eating Disorders. 20: 231-238. PMID 8912035 DOI: 10.1002/(Sici)1098-108X(199611)20:3<231::Aid-Eat2>3.0.Co;2-P  0.48
1996 Garfinkel PE, Lin E, Goering P, Spegg C, Goldbloom D, Kennedy S, Kaplan AS, Woodside DB. Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Evidence from a Canadian community sample British Journal of Psychiatry. 168: 500-506. PMID 8730948 DOI: 10.1192/Bjp.168.4.500  0.48
1995 Davis C, Kennedy SH, Ralevski E, Dionne M, Brewer H, Neitzert C, Ratusny D. Obsessive compulsiveness and physical activity in anorexia nervosa and high-level exercising Journal of Psychosomatic Research. 39: 967-976. PMID 8926606 DOI: 10.1016/0022-3999(95)00064-X  0.48
1995 Garfinkel PE, Kennedy SH, Kaplan AS. Views on classification and diagnosis of eating disorders Canadian Journal of Psychiatry. 40: 445-456. PMID 8681268 DOI: 10.1177/070674379504000805  0.48
1995 Kennedy SH, Katz R, Rockert W, Mendlowitz S, Ralevski E, Clewes J. Assessment of personality disorders in anorexia nervosa and bulimia nervosa: A comparison of self-report and structured interview methods Journal of Nervous and Mental Disease. 183: 358-364. PMID 7798083 DOI: 10.1097/00005053-199506000-00002  0.48
1995 Kennedy SH, Katz R, Neitzert CS, Ralevski E, Mendlowitz S. Exposure with response prevention treatment of anorexia nervosa-bulimic subtype and bulimia nervosa Behaviour Research and Therapy. 33: 685-689. PMID 7654160 DOI: 10.1016/0005-7967(95)00011-L  0.48
1994 Vaccarino FJ, Kennedy SH, Ralevski E, Black R. The effects of growth hormone-releasing factor on food consumption in anorexia nervosa patients and normals. Biological Psychiatry. 35: 446-51. PMID 8018795 DOI: 10.1016/0006-3223(94)90042-6  0.48
1994 Davis C, Kennedy SH, Ravelski E, Dionne M. The Role of Physical Activity in the Development and Maintenance of Eating Disorders Psychological Medicine. 24: 957-967. PMID 7892363 DOI: 10.1017/S0033291700029044  0.48
1994 Kennedy SH, Kaplan AS, Garfinkel PE, Rockert W, Toner B, Abbey SE. Depression in anorexia nervosa and bulimia nervosa: discriminating depressive symptoms and episodes Journal of Psychosomatic Research. 38: 773-782. PMID 7877132 DOI: 10.1016/0022-3999(94)90030-2  0.48
1994 Gallop R, Kennedy SH, Stern D. Therapeutic alliance on an inpatient unit for eating disorders International Journal of Eating Disorders. 16: 405-410. PMID 7866420 DOI: 10.1002/1098-108X(199412)16:4<405::Aid-Eat2260160410>3.0.Co;2-S  0.48
1993 Davis BA, Kennedy SH, Durden DA, D'Souza J, Goldbloom DS, Boulton AA. The effect of the mao-a selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa Progress in Neuropsychopharmacology and Biological Psychiatry. 17: 747-763. PMID 7504824 DOI: 10.1016/0278-5846(93)90057-Y  0.48
1992 DeGroot JM, Kennedy S, Rodin G, McVey G. Correlates of sexual abuse in women with anorexia nervosa and bulimia nervosa Canadian Journal of Psychiatry. 37: 516-518. PMID 1423150 DOI: 10.1177/070674379203700709  0.48
1992 Kennedy SH, Brown GM. Effect of chronic antidepressant treatment with adinazolam and desipramine on melatonin output Psychiatry Research. 43: 177-185. PMID 1410073 DOI: 10.1016/0165-1781(92)90132-M  0.48
1991 Goldbloom DS, Kennedy SH, Swenson JB. Post-residency fellowship training [3] Canadian Journal of Psychiatry. 36: 151. PMID 2044035 DOI: 10.1177/070674379103600225  0.48
1991 Levitt AJ, Brown GM, Kennedy SH, Stern K. Tryptophan treatment and melatonin response in a patient with seasonal affective disorder. Journal of Clinical Psychopharmacology. 11: 74-5. PMID 2040722 DOI: 10.1097/00004714-199102000-00022  0.48
1991 Kennedy SH, Groot JD, Ralevski E, Reed K. A comparison of adinazolam and desipramine in the treatment of major depression International Clinical Psychopharmacology. 6: 65-76. PMID 1960382 DOI: 10.1097/00004850-199100620-00001  0.48
1990 Abbey SE, Toner BB, Garfinkel PE, Kennedy SH, Kaplan AS. Self-report symptoms that predict major depression in patients with prominent physical symptoms International Journal of Psychiatry in Medicine. 20: 247-258. PMID 2265887 DOI: 10.2190/2Ev1-9Tdq-B61C-5Quv  0.48
1989 Garfinkel PE, Kennedy SH, Kaplan AS, Goldbloom DS. The clinician-investigator interface in psychiatry: II - The role of the clinical investigation unit Canadian Journal of Psychiatry. 34: 364-368. PMID 2766188 DOI: 10.1177/070674378903400502  0.48
1989 Kennedy SH, Tighe S, McVey G, Brown GM. Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient Journal of Nervous and Mental Disease. 177: 300-303. PMID 2708973 DOI: 10.1097/00005053-198905000-00009  0.48
1989 Garfinkel PE, Goldbloom DS, Kaplan AS, Kennedy SH. The clinician-investigator interface in psychiatry: I - Values and problems Canadian Journal of Psychiatry. 34: 361-363. PMID 2670172 DOI: 10.1177/070674378903400501  0.48
1988 Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE. A trial of isocarboxazid in the treatment of bulimia nervosa. Journal of Clinical Psychopharmacology. 8: 391-6. PMID 3069879  0.48
1988 Piran N, Lerner P, Garfinkel PE, Kennedy SH, Brouillette C. Personality disorders in anorexic patients International Journal of Eating Disorders. 7: 589-599.  0.48
1986 Kennedy S, Piran N, Garfinkel PE. Isocarboxazid in the treatment of bulimia. The American Journal of Psychiatry. 143: 1495-6. PMID 3535546  0.48
1985 Kennedy SH, Piran N, Garfinkel PE. Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. Journal of Clinical Psychopharmacology. 5: 279-85. PMID 3862680 DOI: 10.1097/00004714-198510000-00005  0.48
1985 Piran N, Kennedy S, Garfinkel PE, Owens M. Affective disturbance in eating disorders. The Journal of Nervous and Mental Disease. 173: 395-400. PMID 3859581  0.48
Show low-probability matches.